Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Challenges to curing primary brain tumours.

Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D, Holland EC, Jones DTW, Joyce JA, Kearns P, Kieran MW, Mellinghoff IK, Merchant M, Pfister SM, Pollard SM, Ramaswamy V, Rich JN, Robinson GW, Rowitch DH, Sampson JH, Taylor MD, Workman P, Gilbertson RJ.

Nat Rev Clin Oncol. 2019 Feb 7. doi: 10.1038/s41571-019-0177-5. [Epub ahead of print] Review.

PMID:
30733593
2.

Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).

Foffi G, Pastore A, Piazza F, Temussi PA.

Phys Biol. 2013 Aug;10(4):040301. Epub 2013 Aug 2.

PMID:
23912807
3.

Functional brain imaging: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2006;6(22):1-79. Epub 2006 Dec 1.

4.

Paediatric brain tumours: A review of radiotherapy, state of the art and challenges for the future regarding protontherapy and carbontherapy.

Laprie A, Hu Y, Alapetite C, Carrie C, Habrand JL, Bolle S, Bondiau PY, Ducassou A, Huchet A, Bertozzi AI, Perel Y, Moyal É, Balosso J; radiotherapy committee of SFCE and France Hadron.

Cancer Radiother. 2015 Dec;19(8):775-89. doi: 10.1016/j.canrad.2015.05.028. Epub 2015 Nov 6. Review.

PMID:
26548600
5.
6.

Consensus document on European brain research.

Olesen J, Baker MG, Freund T, di Luca M, Mendlewicz J, Ragan I, Westphal M.

J Neurol Neurosurg Psychiatry. 2006 Aug;77 Suppl 1:i1-49. Erratum in: J Neurol Neurosurg Psychiatry. 2010 Dec;81(12)1414.

7.

The molecular genomics of metastatic brain tumours.

Bollig-Fischer A, Michelhaugh S, Ali-Fehmi R, Mittal S.

OA Mol Oncol. 2013 Apr 1;1(1). pii: https://www.oapublishinglondon.com/article/759#.

8.

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.

Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):67-74. doi: 10.1016/j.ejso.2017.09.025. Epub 2017 Nov 3. Review.

PMID:
29108961
9.

The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusions.

Glimelius B, Bergh J, Brandt L, Brorsson B, Gunnars B, Hafström L, Haglund U, Högberg T, Janunger KG, Jönsson PE, Karlsson G, Kimby E, Lamnevik G, Nilsson S, Permert J, Ragnhammar P, Sörenson S, Nygren P.

Acta Oncol. 2001;40(2-3):135-54. Review.

PMID:
11441927
10.

Drug delivery to brain tumours: challenges and progress.

Ningaraj NS.

Expert Opin Drug Deliv. 2006 Jul;3(4):499-509. Review.

PMID:
16822225
11.

Cancer stem cells in the mammalian central nervous system.

Pilkington GJ.

Cell Prolif. 2005 Dec;38(6):423-33. Review.

PMID:
16300654
12.

Advancing drug therapy for brain tumours: a current review of the pro-inflammatory peptide Substance P and its antagonists as anti-cancer agents.

Mander K, Harford-Wright E, Lewis KM, Vink R.

Recent Pat CNS Drug Discov. 2014;9(2):110-21. Review.

PMID:
25386916
13.

Potential clinical role of telomere length in human glioblastoma.

La Torre D, Aguennouz M, Conti A, Giusa M, Raffa G, Abbritti RV, Germano' A, Angileri FF.

Transl Med UniSa. 2011 Oct 17;1:243-70. Print 2011 Sep.

14.

The role of CT body scans in the investigation of patients with newly diagnosed brain tumours.

Bailey M, Qureshi A, Kamaly-Asl I.

Br J Neurosurg. 2014 Jun;28(3):347-50. doi: 10.3109/02688697.2013.847169. Epub 2013 Oct 10.

PMID:
24111709
15.

Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial.

Cranston A, Stocken DD, Stamp E, Roblin D, Hamlin J, Langtry J, Plummer R, Ashworth A, Burn J, Rajan N.

Trials. 2017 Mar 7;18(1):111. doi: 10.1186/s13063-017-1812-z.

16.

Cellular immortality in brain tumours: an integration of the cancer stem cell paradigm.

Rahman R, Heath R, Grundy R.

Biochim Biophys Acta. 2009 Apr;1792(4):280-8. doi: 10.1016/j.bbadis.2009.01.011. Epub 2009 Jan 31. Review.

17.

Multidrug resistance in cancer.

Baguley BC.

Methods Mol Biol. 2010;596:1-14. doi: 10.1007/978-1-60761-416-6_1. Review.

PMID:
19949917
18.

Objective image analysis of real-time three-dimensional intraoperative ultrasound for intrinsic brain tumour surgery.

Camp SJ, Apostolopoulos V, Raptopoulos V, Mehta A, O'Neill K, Awad M, Vaqas B, Peterson D, Roncaroli F, Nandi D.

J Ther Ultrasound. 2017 Feb 16;5:2. doi: 10.1186/s40349-017-0084-0. eCollection 2017.

19.

Exploring access to rehabilitation services from allied health professionals for patients with primary high-grade brain tumours.

McCartney A, Butler C, Acreman S.

Palliat Med. 2011 Dec;25(8):788-96. doi: 10.1177/0269216311398699. Epub 2011 Mar 10.

PMID:
21393353
20.

Supplemental Content

Support Center